C

Cheryl Mai

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0001-6214-2520

Publishes on T-cell and B-cell Immunology, Gut microbiota and health, Cancer Immunotherapy and Biomarkers. 3 papers and 875 citations.

3Publications
875Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Imaging Extracellular Lactate In Vitro and In Vivo Using CEST MRI and a Paramagnetic Shift Reagent
Lei Zhang, André F. Martins, Cheryl Mai et al.|Chemistry - A European Journal|2016
Cited by 29

Overproduction of lactate is a hallmark of cancer, yet a method to quantitatively measure lactate production by cancer cells is not straight-forward. Chemical exchange saturation transfer magnetic resonance imaging (CEST MRI) can potentially be used to image lactate but the small difference in chemical shift of the lactate -OH proton and water proton resonances make it challenging. Like other spectroscopic methods, CEST MRI cannot discriminate intracellular lactate from extracellular lactate. Herein, we demonstrate a relatively simple way to shift the lactate -OH proton resonance far away from water by addition of the paramagnetic shift reagent, EuDO3A, while retaining the CEST properties of lactate itself. The potential of the method was demonstrated by imaging extracellular lactate excreted from lung cancer cells in tissue culture without interference from other components in the culture media and by imaging excess lactate excreted into the bladder of a mouse.

Opposing functions of distinct regulatory T cell subsets in colorectal cancer
Xiao Huang, Dan Feng, Sneha Mitra et al.|Immunity|2025
Cited by 1Open Access

Treg cells exhibited opposite enrichment patterns in adjacent normal colon tissues and tumors. Transcriptionally similar Treg subsets were observed across different human barrier tissue tumors. This functional dichotomy between Treg subsets may enable selective targeting of the pro-tumoral subset while preserving its anti-tumoral counterpart in CRC and other barrier tissue cancers.